Bioanalytical method validation decides whether a pharmacokinetic or residue study produces usable numbers. One recent assay for a parent drug and two metabolites in dog plasma cleared the full package in a 4.0-minute run: correlation coefficients above 0.9997, matrix effects between 93.27 and 104.59 percent, and recovery above 80.22 percent from a single protein-precipitation step. For a veterinary API producer that package is not academic. A withdrawal-period study for norfloxacin or sulfadimidine rests on an assay that quantifies the parent compound in the target species at concentrations low enough to see the tail of the depletion curve. Get the validation wrong and the withdrawal period is wrong with it. Why plasma assays carry more risk than product release testing A release test measures a known concentration in a clean matrix, which is why bioanalytical method validation is a different discipline from product release testing. A plasma assay measures an unknown concentration in ...
Luoyang Zhengmu Bio-Tech Co., Ltd.
Professional manufacturer of Sulfadimidine, Sulfadimidine Sodium, Sulfadiazine, Sulfadiazine Sodium, Norfloxacin HCL, Norfloxacin Nicotinate, Norfloxacin...